Liquidia (LQDA) EBIT Growth (1y) (2021 - 2026)
Liquidia (LQDA) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -14.89% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -46.83% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 719.49% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -450.06% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -20.32% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -235.28% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 273.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273.62% |
| Dec 31, 2025 | 154.80% |
| Sep 30, 2025 | 106.05% |
| Jun 30, 2025 | -37.90% |
| Mar 31, 2025 | -23.00% |
| Dec 31, 2024 | -36.58% |
| Sep 30, 2024 | -96.02% |
| Jun 30, 2024 | -19.15% |
| Mar 31, 2024 | -211.97% |
| Dec 31, 2023 | -306.90% |
| Sep 30, 2023 | -68.62% |
| Jun 30, 2023 | -154.46% |
| Mar 31, 2023 | 36.21% |
| Dec 31, 2022 | 42.82% |
| Sep 30, 2022 | -24.73% |
| Jun 30, 2022 | -41.17% |
| Mar 31, 2022 | -60.78% |
| Dec 31, 2021 | 28.60% |
| Sep 30, 2021 | 52.20% |
| Jun 30, 2021 | 53.68% |